查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1547332

全球甲真菌病治疗市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Onychomycosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

全球甲真菌病治疗市场需求预计将从 2023 年的 55.8 亿美元达到近 95.6 亿美元的市场规模，2024-2032 年研究期间复合年增长率为 6.16%。

甲真菌病是一种手指甲和脚趾甲的真菌感染，表现为指甲变色、增厚并与甲床分离。它可以涉及任何指甲部件，例如甲板、指甲基质和甲床。这种情况也称为甲癣或皮癣菌性甲癣。引起甲癣的三种主要真菌是酵母菌、皮癣菌和非皮癣菌霉菌。甲真菌病可以局部治疗和口服治疗。口服和局部治疗相结合预计将显示出有效的结果。目前最有效的甲癣治疗方法是全身性抗真菌药物，但治癒率远低于100%，即使治疗后也可能復发。该疾病还可以透过雷射疗法和光动力疗法来治疗。然而，治癒甲癣需要较长的治疗时间。

市场动态

甲真菌病治疗市场在未来几年呈现出充满希望的成长机会。推动市场的关键因素是糖尿病、牛皮癣和周边血管疾病等慢性病的盛行率不断上升，以及全球老年人口数量的增加。患有糖尿病的人患甲癣的几率比一般人高 1.9 至 2.8。事实上，皮肤科医生和足病医生越来越意识到甲癣的治疗方法以及个人保持指甲美观的趋势。由于指甲出汗、经常穿鞋和指甲受伤，运动员甲癣发生率不断增加，甲癣治疗市场也将受到青睐。促进市场成长的其他因素是生活方式的改变，包括使用健身房和公共游泳池等活动。此外，采用新药治疗这种疾病、透过线上商店销售甲癣治疗产品的激增以及市场参与者的策略伙伴关係、合併和合作将推动市场成长。然而，与甲癣治疗药物相关的副作用以及对甲癣的认识缺乏可能会限制甲癣治疗市场。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球甲癣治疗市场的各个细分市场进行了包容性评估。甲真菌病治疗行业的成长和趋势为本研究提供了整体方法。

市场区隔

甲真菌病治疗市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 远端甲下甲癣 (DSO)
  • 白色表浅甲癣 (WSO)
  • 近端甲下甲真菌病 (PSO)
  • 念珠菌甲真菌病
  • 其他的

按治疗类型

  • 药物治疗
  • 局部治疗

按药物类别

  • 烯丙胺
  • 唑类
  • 灰黄霉素
  • 其他的

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲甲癣治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。甲真菌病治疗市场的主要参与者包括辉瑞公司、诺华公司、强生服务公司、Medimetriks Pharmaceuticals Inc.、Bausch Health Sciences、Galderma Laboratories、Moberg Pharma AB、Dr. Reddy'S Laboratories Ltd、Merz Pharma、Kaken Pharmaceutical Co. Ltd 、GlaxoSmithKline Plc、Taro Pharmaceuticals Industries Ltd。 。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：甲真菌病治疗 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按治疗类型进行的市场吸引力分析
    • 按药品类别分類的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球甲癣治疗市场分析：按类型

  • 按类型概述
  • 按类型分析历史和预测数据
  • 远端甲下甲癣 (DSO)
  • 白色表浅甲癣 (WSO)
  • 近端甲下甲真菌病 (PSO)
  • 念珠菌甲真菌病
  • 其他的

第 6 章：全球甲癣治疗市场分析：依治疗类型

  • 按治疗类型概述
  • 按治疗类型进行历史和预测数据分析
  • 药物治疗
  • 局部治疗

第 7 章：全球甲癣治疗市场分析：按药物类别

  • 按药物类别概述
  • 按药物类别进行历史和预测数据分析
  • 烯丙胺
  • 唑类
  • 灰黄霉素
  • 其他的

第 8 章：全球甲癣治疗市场分析：按分销管道

  • 配销通路概述
  • 按配销通路进行历史和预测资料分析
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章：全球甲癣治疗市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区按国家销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲按国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：甲真菌病治疗公司的竞争格局

  • 甲真菌病治疗市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • Pfizer Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Novartis AG
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Johnson & Johnson Services Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Medimetriks Pharmaceuticals Inc.
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Bausch Health Sciences
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Galderma Laboratories
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Moberg Pharma AB
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Dr. Reddy'S Laboratories Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Merz Pharma
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Kaken Pharmaceutical Co. Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • GlaxoSmithKline Plc
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态
  • Taro Pharmaceuticals Industries Ltd
    • 公司概况
    • 公司收入
    • 产品
    • 最新动态

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

Product Code: VMR11215983

The global demand for Onychomycosis Treatment Market is presumed to reach the market size of nearly USD 9.56 Billion by 2032 from USD 5.58 Billion in 2023 with a CAGR of 6.16% under the study period 2024-2032.

Onychomycosis is a kind of fungal infection of fingernails and toenails in which the nails appear to be discolored, thickened, and separated from the nail bed. It may involve any nail component such as a nail plate, nail matrix, and nail bed. This condition is also known as tinea unguium or dermatophytic onychomycosis. The three main types of fungi responsible for causing onychomycosis are yeasts, dermatophytes, and non dermatophyte molds. Onychomycosis can be treated both topically and orally. A combination of oral and topical treatment is expected to show effective results. The most effective onychomycosis treatment available is systemic antifungal agents, but the cure rate is far below 100%, and it may recur even after treatment. The disease can also be treated with laser therapy and photodynamic therapy. However, curing onychomycosis involves a longer treatment duration.

MARKET DYNAMICS

The onychomycosis treatment market shows promising growth opportunities in the coming years. The key factors driving the market are the growing prevalence of chronic diseases like diabetes mellitus, psoriasis, and peripheral vascular disease and a rise in the number of senior population across the globe. People suffering from diabetes mellitus are 1.9 to 2.8 more prone to onychomycosis. The fact that dermatologists and podiatrists are becoming more aware of onychomycosis therapeutics and the growing trend among individuals to maintain the aesthetic appeal of the nails. The onychomycosis treatment market will also be favored by increasing onychomycosis incidence among athletes owing to nail sweating, constant use of shoes, and nail injuries. Other factors contributing to the market growth are changing lifestyles that include activities such as using gyms and public swimming pools. Furthermore, adopting novel drugs for treating the disease, a surge in onychomycosis treatment product sale through online stores, and strategic partnerships, mergers, and collaborations by market players will propel market growth. However, side-effects related to onychomycosis treatment drugs and lack of awareness about onychomycosis may limit the onychomycosis treatment market.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Onychomycosis Treatment. The growth and trends of Onychomycosis Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Onychomycosis Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Distal Subungual Onychomycosis (DSO)
  • White Superficial Onychomycosis (WSO)
  • Proximal Subungual Onychomycosis (PSO)
  • Candida Onychomycosis
  • Others

By Treatment Type

  • Drug Treatment
  • Topical Therapy

By Drug Class

  • Allylamine
  • Azole
  • Griseofulvin
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Onychomycosis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Onychomycosis Treatment market include Pfizer Inc., Novartis AG, Johnson & Johnson Services Inc., Medimetriks Pharmaceuticals Inc., Bausch Health Sciences, Galderma Laboratories, Moberg Pharma AB, Dr. Reddy'S Laboratories Ltd, Merz Pharma, Kaken Pharmaceutical Co. Ltd, GlaxoSmithKline Plc, Taro Pharmaceuticals Industries Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. ONYCHOMYCOSIS TREATMENT - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Treatment Type
    • 3.7.3 Market Attractiveness Analysis By Drug Class
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS BY TYPE

  • 5.1. Overview By Type
  • 5.2. Historical and Forecast Data Analysis By Type
  • 5.3. Distal Subungual Onychomycosis (DSO) Historic and Forecast Sales By Regions
  • 5.4. White Superficial Onychomycosis (WSO) Historic and Forecast Sales By Regions
  • 5.5. Proximal Subungual Onychomycosis (PSO) Historic and Forecast Sales By Regions
  • 5.6. Candida Onychomycosis Historic and Forecast Sales By Regions
  • 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS BY TREATMENT TYPE

  • 6.1. Overview By Treatment Type
  • 6.2. Historical and Forecast Data Analysis By Treatment Type
  • 6.3. Drug Treatment Historic and Forecast Sales By Regions
  • 6.4. Topical Therapy Historic and Forecast Sales By Regions

7. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS BY DRUG CLASS

  • 7.1. Overview By Drug Class
  • 7.2. Historical and Forecast Data Analysis By Drug Class
  • 7.3. Allylamine Historic and Forecast Sales By Regions
  • 7.4. Azole Historic and Forecast Sales By Regions
  • 7.5. Griseofulvin Historic and Forecast Sales By Regions
  • 7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1. Overview By Distribution Channel
  • 8.2. Historical and Forecast Data Analysis By Distribution Channel
  • 8.3. Hospital Pharmacies Historic and Forecast Sales By Regions
  • 8.4. Retail Pharmacies Historic and Forecast Sales By Regions
  • 8.5. Online Pharmacies Historic and Forecast Sales By Regions

9. GLOBAL ONYCHOMYCOSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2 North America By Segment Sales Analysis
    • 9.3.3 North America By Country Sales Analysis
    • 9.3.4 United States Sales Analysis
    • 9.3.5 Canada Sales Analysis
    • 9.3.6 Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2 Europe By Segment Sales Analysis
    • 9.4.3 Europe By Country Sales Analysis
    • 9.4.4 United Kingdom Sales Analysis
    • 9.4.5 France Sales Analysis
    • 9.4.6 Germany Sales Analysis
    • 9.4.7 Italy Sales Analysis
    • 9.4.8 Russia Sales Analysis
    • 9.4.9 Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2 Asia Pacific By Segment Sales Analysis
    • 9.5.3 Asia Pacific By Country Sales Analysis
    • 9.5.4 China Sales Analysis
    • 9.5.5 India Sales Analysis
    • 9.5.6 Japan Sales Analysis
    • 9.5.7 South Korea Sales Analysis
    • 9.5.8 Australia Sales Analysis
    • 9.5.9 South East Asia Sales Analysis
    • 9.5.10 Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2 Latin America By Segment Sales Analysis
    • 9.6.3 Latin America By Country Sales Analysis
    • 9.6.4 Brazil Sales Analysis
    • 9.6.5 Argentina Sales Analysis
    • 9.6.6 Peru Sales Analysis
    • 9.6.7 Chile Sales Analysis
    • 9.6.8 Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2 Middle East & Africa By Segment Sales Analysis
    • 9.7.3 Middle East & Africa By Country Sales Analysis
    • 9.7.4 Saudi Arabia Sales Analysis
    • 9.7.5 UAE Sales Analysis
    • 9.7.6 Israel Sales Analysis
    • 9.7.7 South Africa Sales Analysis
    • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE ONYCHOMYCOSIS TREATMENT COMPANIES

  • 10.1. Onychomycosis Treatment Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11. COMPANY PROFILES OF ONYCHOMYCOSIS TREATMENT INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Pfizer Inc.
    • 11.3.1 Company Overview
    • 11.3.2 Company Revenue
    • 11.3.3 Products
    • 11.3.4 Recent Developments
  • 11.4. Novartis AG
    • 11.4.1 Company Overview
    • 11.4.2 Company Revenue
    • 11.4.3 Products
    • 11.4.4 Recent Developments
  • 11.5. Johnson & Johnson Services Inc.
    • 11.5.1 Company Overview
    • 11.5.2 Company Revenue
    • 11.5.3 Products
    • 11.5.4 Recent Developments
  • 11.6. Medimetriks Pharmaceuticals Inc.
    • 11.6.1 Company Overview
    • 11.6.2 Company Revenue
    • 11.6.3 Products
    • 11.6.4 Recent Developments
  • 11.7. Bausch Health Sciences
    • 11.7.1 Company Overview
    • 11.7.2 Company Revenue
    • 11.7.3 Products
    • 11.7.4 Recent Developments
  • 11.8. Galderma Laboratories
    • 11.8.1 Company Overview
    • 11.8.2 Company Revenue
    • 11.8.3 Products
    • 11.8.4 Recent Developments
  • 11.9. Moberg Pharma AB
    • 11.9.1 Company Overview
    • 11.9.2 Company Revenue
    • 11.9.3 Products
    • 11.9.4 Recent Developments
  • 11.10. Dr. Reddy'S Laboratories Ltd
    • 11.10.1 Company Overview
    • 11.10.2 Company Revenue
    • 11.10.3 Products
    • 11.10.4 Recent Developments
  • 11.11. Merz Pharma
    • 11.11.1 Company Overview
    • 11.11.2 Company Revenue
    • 11.11.3 Products
    • 11.11.4 Recent Developments
  • 11.12. Kaken Pharmaceutical Co. Ltd
    • 11.12.1 Company Overview
    • 11.12.2 Company Revenue
    • 11.12.3 Products
    • 11.12.4 Recent Developments
  • 11.13. GlaxoSmithKline Plc
    • 11.13.1 Company Overview
    • 11.13.2 Company Revenue
    • 11.13.3 Products
    • 11.13.4 Recent Developments
  • 11.14. Taro Pharmaceuticals Industries Ltd
    • 11.14.1 Company Overview
    • 11.14.2 Company Revenue
    • 11.14.3 Products
    • 11.14.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Type (USD MN)
  • Distal Subungual Onychomycosis (DSO) Market Sales By Geography (USD MN)
  • White Superficial Onychomycosis (WSO) Market Sales By Geography (USD MN)
  • Proximal Subungual Onychomycosis (PSO) Market Sales By Geography (USD MN)
  • Candida Onychomycosis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Treatment Type (USD MN)
  • Drug Treatment Market Sales By Geography (USD MN)
  • Topical Therapy Market Sales By Geography (USD MN)
  • Analysis By Drug Class (USD MN)
  • Allylamine Market Sales By Geography (USD MN)
  • Azole Market Sales By Geography (USD MN)
  • Griseofulvin Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Onychomycosis Treatment Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Onychomycosis Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Onychomycosis Treatment Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Type
  • Market Attractiveness Analysis By Treatment Type
  • Market Attractiveness Analysis By Drug Class
  • Market Attractiveness Analysis By Distribution Channel
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Type (USD MN)
  • Distal Subungual Onychomycosis (DSO) Market Sales By Geography (USD MN)
  • White Superficial Onychomycosis (WSO) Market Sales By Geography (USD MN)
  • Proximal Subungual Onychomycosis (PSO) Market Sales By Geography (USD MN)
  • Candida Onychomycosis Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Treatment Type (USD MN)
  • Drug Treatment Market Sales By Geography (USD MN)
  • Topical Therapy Market Sales By Geography (USD MN)
  • Global Market Analysis By Drug Class (USD MN)
  • Allylamine Market Sales By Geography (USD MN)
  • Azole Market Sales By Geography (USD MN)
  • Griseofulvin Market Sales By Geography (USD MN)
  • Others Market Sales By Geography (USD MN)
  • Global Market Analysis By Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales By Geography (USD MN)
  • Retail Pharmacies Market Sales By Geography (USD MN)
  • Online Pharmacies Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.